ArticleDiagnostics (Basel, Switzerland)2026
The Prognostic Role of the Lung Immune Prognostic Index in Neuroendocrine Prostate Cancer: A Multicenter Retrospective Study.
Merve Turan, Mehmet Nuri Baser, Fatima Ozkaya Kutluay, Ahmet Unlu, Ozlem Kutlu, Umut Cakıroglu, Asim Armagan Aydin, Olcun Umit Unal, Gamze Gokoz Dogu, Esin Oktay
Abstract read
In one paragraphArticle in Diagnostics (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from itWhat it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
10 authors.
Merve TuranDepartment of Medical Oncology, Faculty of Medicine, Aydin Adnan Menderes University, Zafer Neighborhood, 09100 Aydin, Turkey.ORCID 0000-0003-4021-6095 Mehmet Nuri BaserDepartment of Medical Oncology, Faculty of Medicine, Aydin Adnan Menderes University, Zafer Neighborhood, 09100 Aydin, Turkey.ORCID 0000-0003-1809-5581 Fatima Ozkaya KutluayDepartment of Medical Oncology, Faculty of Medicine, Pamukkale University, 20070 Denizli, Turkey.ORCID 0000-0002-8284-6565 Ahmet UnluDepartment of Medical Oncology, Antalya Education and Research Hospital, University of Health Sciences, 07100 Antalya, Turkey.ORCID 0000-0001-6654-3815 Ozlem KutluDepartment of Medical Oncology, Izmir City Hospital, University of Health Sciences, 35540 Izmir, Turkey.ORCID 0000-0001-5050-3333 Umut CakırogluDepartment of Medical Oncology, Izmir City Hospital, University of Health Sciences, 35540 Izmir, Turkey.ORCID 0000-0002-3274-2565 Asim Armagan AydinDepartment of Medical Oncology, Antalya Education and Research Hospital, University of Health Sciences, 07100 Antalya, Turkey.ORCID 0000-0001-8749-9825 Olcun Umit UnalDepartment of Medical Oncology, Izmir City Hospital, University of Health Sciences, 35540 Izmir, Turkey.ORCID 0000-0001-7698-3574 Gamze Gokoz DoguDepartment of Medical Oncology, Faculty of Medicine, Pamukkale University, 20070 Denizli, Turkey.ORCID 0000-0001-8142-0362 Esin OktayDepartment of Medical Oncology, Faculty of Medicine, Aydin Adnan Menderes University, Zafer Neighborhood, 09100 Aydin, Turkey.ORCID 0000-0002-5974-6339 Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
LIPILung Immune Prognostic Indexneuroendocrine prostate canceroverall survivalprognostic biomarkersystemic inflammation
Identifiers
PMID42739268
PMCPMC13564591
What OpenQuestion holds
Textmetadata
Read underepoch 390